Salvatore Alfieri

2.8k total citations
93 papers, 1.6k citations indexed

About

Salvatore Alfieri is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Salvatore Alfieri has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 39 papers in Otorhinolaryngology and 27 papers in Surgery. Recurrent topics in Salvatore Alfieri's work include Head and Neck Cancer Studies (39 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Diagnosis and Treatment (13 papers). Salvatore Alfieri is often cited by papers focused on Head and Neck Cancer Studies (39 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Diagnosis and Treatment (13 papers). Salvatore Alfieri collaborates with scholars based in Italy, United States and Switzerland. Salvatore Alfieri's co-authors include Paolo Bossi, Lisa Licitra, Cristiana Bergamini, Laura D. Locati, Carlo Resteghini, Roberta Granata, Ester Orlandi, Stefano Cavalieri, Nicola Alessandro Iacovelli and Donata Galbiati and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Salvatore Alfieri

89 papers receiving 1.6k citations

Peers

Countries citing papers authored by Salvatore Alfieri

Since Specialization

Citations

This map shows the geographic impact of Salvatore Alfieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Alfieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Alfieri more than expected).

Fields of papers citing papers by Salvatore Alfieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Alfieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Alfieri. The network helps show where Salvatore Alfieri may publish in the future.

Co-authorship network of co-authors of Salvatore Alfieri

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Alfieri. A scholar is included among the top collaborators of Salvatore Alfieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Alfieri. Salvatore Alfieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study 2025 ·European Journal of Cancer ·Salvatore Alfieri, (unknown), Sara Marceglia, (unknown), (unknown), (unknown), (unknown), (unknown), Stefano Cavalieri, Cristiana Bergamini, Elena Colombo, (unknown), Loris De Cecco, (unknown), Nicola Alessandro Iacovelli, Marco Guzzo, Ester Orlandi, Laura D. Locati, Paolo Bossi, Lisa Licitra, Francesca Taverna	0
2	Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial 2025 ·European Journal of Cancer ·Paolo Bossi, Andrea Alberti, Cristiana Bergamini, Carlo Resteghini, Laura D. Locati, Salvatore Alfieri, Stefano Cavalieri, Elena Colombo, Cristina Gurizzan, Luigi Lorini, Valeria Tovazzi, Manuel Zamparini, Marco Ravanelli, Paolo A. Ascierto, Vittorio Rampinelli, Alberto Grammatica, Roberto Patuzzo, Andrea Maurichi, Lisa Licitra	3
3	Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study 2024 ·Acta Oncologica ·Rosalba Miceli, Hanna Eriksson, Giuseppe Lo Russo, Salvatore Alfieri, Maria Moksnes Bjaanæs, Filippo Pietrantonio, Loris De Cecco, Arsela Prelaj, Claudia Proto, (unknown), (unknown), (unknown), (unknown), Laura Mazzeo, Patrizia Giannatempo, Elena Verzoni, John Crown, Åslaug Helland, Alex J. Eustace	3
4	891P Pembrolizumab and olaparib in recurrent/metastatic, platinum resistant nasopharyngeal cancer: The POINT study 2024 ·Annals of Oncology ·Cristina Gurizzan, (unknown), Adriana Alberti, (unknown), Carlo Resteghini, Salvatore Alfieri, Cristiana Bergamini, Francesco Perri, Giacomo Moretti, Danilo Galizia, (unknown), (unknown), Simona Secondino, Manuel Zamparini, (unknown), Paolo Bossi	1
5	Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era? 2024 ·Cancers ·Francesco Perri, Roberta Fusco, Francesco Sabbatino, Morena Fasano, Alessandro Ottaiano, Marco Cascella, (unknown), (unknown), Giovanni Salzano, (unknown), Massimo Montano, (unknown), Roberta D’Aniello, Piera Maiolino, Fortunato Ciardiello, (unknown), Salvatore Alfieri, Franco Ionna	2
6	Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 2023 ·Oral Oncology ·Stefano Cavalieri, Francesca Platini, Francesco Barretta, (unknown), (unknown), Cristiana Bergamini, Carlo Resteghini, Elena Colombo, Nicola Alessandro Iacovelli, Marzia Franceschini, Giuseppina Calareso, (unknown), (unknown), (unknown), Luisa Toffolatti, Mauro Guglielmo, Carla Ripamonti, Laura Cosmai, Lisa Licitra, Salvatore Alfieri	4
7	A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study 2023 ·Critical Reviews in Oncology/Hematology ·Giorgio Bogani, Michela Cinquini, Diego Signorelli, Elio Gregory Pizzutilo, (unknown), Melissa Bersanelli, Daniele Raggi, Salvatore Alfieri, Sebastiano Buti, Federica Bertolini, Pierluigi Bonomo, Laura Marandino, Mimma Rizzo, Marta Monteforte, Marco Maria Aiello, Antonino Carmelo Tralongo, Valter Torri, Violante Di Donato, Patrizia Giannatempo	15
8	Management of patients with skin adnexal carcinomas 2023 ·SHILAP Revista de lepidopterología ·Stefano Cavalieri, Cristiana Bergamini, Salvatore Alfieri, Carlo Resteghini, (unknown), Elena Colombo, (unknown), Lisa Licitra	2
9	Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 2023 ·Frontiers in Oncology ·Cristiana Bergamini, Stefano Cavalieri, Carlo Resteghini, Salvatore Alfieri, (unknown), Elena Colombo, (unknown), Giuseppina Calareso, Andrea Vingiani, Nicola Alessandro Iacovelli, Marzia Franceschini, Marco Guzzo, Alberto Deganello, Lisa Licitra	1
10	The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 2022 ·Cancers ·Stefano Cavalieri, Paolo Bossi, Gabriele Infante, Rosalba Miceli, Nicola Alessandro Iacovelli, (unknown), Laura D. Locati, Cristiana Bergamini, Carlo Resteghini, (unknown), Salvatore Alfieri, Elena Colombo, Rossana Ingargiola, Marzia Franceschini, Giuseppina Calareso, Lisa Licitra, Ester Orlandi	2
11	Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 2021 ·SHILAP Revista de lepidopterología ·Stefano Cavalieri, (unknown), (unknown), Cristiana Bergamini, Carlo Resteghini, Elena Colombo, (unknown), (unknown), Salvatore Alfieri, Lisa Licitra, Laura D. Locati	7
12	Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 2021 ·Cancers ·Anna Cavallo, Nicola Alessandro Iacovelli, (unknown), T. Rancati, Salvatore Alfieri, (unknown), A. Cicchetti, C. Fallai, Rossana Ingargiola, Lisa Licitra, Laura D. Locati, Stefano Cavalieri, E. Pignoli, (unknown), R. Valdagni, Ester Orlandi	2
13	Clinical and Socio-demographic Variables Associated with the Outcome of Vocational Rehabilitation Programs: A Community-Based Italian Study 2020 ·Community Mental Health Journal ·Giorgio Mattei, Giulia Venturi⋄, Salvatore Alfieri, (unknown), Sílvia Ferrari, Marco Rigatelli, Fabrizio Starace, Gian Maria Galeazzi	2
14	Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 2020 ·Cancers ·Salvatore Alfieri, (unknown), Francesca Platini, (unknown), Federica Perrone, Donata Galbiati, (unknown), Roberta Depenni, Andrea Vingiani, Pasquale Quattrone, Edoardo Marchesi, (unknown), (unknown), Elisa Mancinelli, Ester Orlandi, Sara Marceglia, Laura D. Locati, Lisa Licitra, Paolo Bossi, Loris De Cecco	12
15	Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature 2019 ·Critical Reviews in Oncology/Hematology ·Paolo Bossi, Salvatore Alfieri, Primož Strojan, Robert P. Takes, Fernando López, Antti Mäkitie, Nabil F. Saba, Juan P. Rodrigo, Carol R. Bradford, Carlos Suárez, Mark Zafereo, Arlene A. Forastiere, Jan B. Vermorken, Miquel Quer, Álvaro Sanabria, Ricard Simó, Remco de Bree, Alessandra Rinaldo, Alfio Ferlito	45
16	Stakeholders’ views on vocational rehabilitation programs: a call for collaboration with Occupational Health Physicians 2018 ·La Medicina del lavoro ·Giorgio Mattei, (unknown), Salvatore Alfieri, (unknown), (unknown), Sílvia Ferrari, (unknown), Fabriziomaria Gobba, Alberto Modenese, Luca Pingani, Marco Rigatelli, (unknown), Giulia Venturi⋄, Fabrizio Starace, Gian Maria Galeazzi	6
17	Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 2018 ·La radiologia medica ·Alessandra Alessi, Alice Lorenzoni, Anna Cavallo, (unknown), Nicola Alessandro Iacovelli, Paolo Bossi, Salvatore Alfieri, Gianluca Serafini, (unknown), A. Cicchetti, Marta Mira-Aladrén, Lisa Licitra, C. Fallai, Flavio Crippa, Ester Orlandi	16
18	Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling 2017 ·Value in Health ·Michela Meregaglia, John Cairns, Salvatore Alfieri, (unknown), (unknown), Ester Orlandi, Lisa Licitra, Paolo Bossi	13
19	Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience 2017 ·Targeted Oncology ·Salvatore Alfieri, Cristiana Bergamini, Roberta Granata, Laura D. Locati, Lisa Licitra, Paolo Bossi	10
20	A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 2017 ·Annals of Oncology ·Paolo Bossi, Diego Cortinovis, Sonia Fatigoni, Maria Cossu Rocca, Alessandra Fabi, Patrizia Seminara, Carla B. Ripamonti, Salvatore Alfieri, Roberta Granata, Cristiana Bergamini, Francesco Agustoni, Paolo Bidoli, Franco Nolè, M.A. Pessi, (unknown), (unknown), Federica Montanaro, Fausto Roila	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nerina Denaro Breakdown of academic impact, for papers by Cristiana Bergamini Breakdown of academic impact, for papers by Marcos Brasilino de Carvalho Breakdown of academic impact, for papers by Yusuke Onozawa Breakdown of academic impact, for papers by Mario Airoldi Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by Antonio Antón Breakdown of academic impact, for papers by Hsuan‐Chih Hsu